Results 251 to 260 of about 936,523 (298)
Some of the next articles are maybe not open access.
A case of bronchogenic cyst with high production of antigen CA 19–9
Cancer, 1989A 35-year-old man was hospitalized with complaints of retrosternal pain and high fever. A chest radiograph showed a large round mass in the mediastinum. Of the several tumor markers in the serum tested, only CA 19-9 was elevated. Thoracotomy revealed a cystic mass with purulent hemorrhagic materials.
A, Okubo +6 more
openaire +2 more sources
Digestion, 2009
The serum carbohydrate antigenic determinant (CA 19–9) was assayed in patients with various diseases, and it provides excellent sensitivity for adenocarcinoma of the pancreas (25/27, 93%), while only 4% (2/54) of the patients with benign diseases and none of the 40 healthy subjects showed elevated CA 19–9 concentrations over 37 units/ml as upper normal
T, Yoshikawa +4 more
openaire +2 more sources
The serum carbohydrate antigenic determinant (CA 19–9) was assayed in patients with various diseases, and it provides excellent sensitivity for adenocarcinoma of the pancreas (25/27, 93%), while only 4% (2/54) of the patients with benign diseases and none of the 40 healthy subjects showed elevated CA 19–9 concentrations over 37 units/ml as upper normal
T, Yoshikawa +4 more
openaire +2 more sources
Serum carbohydrate antigen (CA) 19-9 as a prognostic factor in cholangiocarcinoma: A meta-analysis
Frontiers of Medicine in China, 2010This study was performed to determine the prognostic role of preoperative serum carbohydrate antigen (CA) 19-9 levels in the survival of patients with cholangiocarcinoma. Articles published up to June 1(st), 2010 that evaluated preoperative CA19-9 levels and the prognosis of cholangiocarcinoma were collected for meta-analysis.
Shang-Long, Liu +6 more
openaire +2 more sources
Rheumatoid factor interference in the determination of carbohydrate antigen 19-9 (CA 19-9)
Clinical Chemistry and Laboratory Medicine (CCLM), 2006AbstractClin Chem Lab Med 2006;44:1137–9.
Mario, Berth +6 more
openaire +2 more sources
1995
This tumour-associated antigen is a high molecular weight mucin epitope expression is defined by a homologous monoclonal antibody system — the CA 19-9 antibody The antigenic epitope represents a sialylated Lewisa blood group pentasaccharide and, as such, is similar to that detected by some other monocloncal antibody systems.
openaire +1 more source
This tumour-associated antigen is a high molecular weight mucin epitope expression is defined by a homologous monoclonal antibody system — the CA 19-9 antibody The antigenic epitope represents a sialylated Lewisa blood group pentasaccharide and, as such, is similar to that detected by some other monocloncal antibody systems.
openaire +1 more source
[Carbohydrate antigen CA 19-9: value in pancreatic pathology].
Gastroenterologie clinique et biologique, 1986In order to determine the diagnostic usefulness of the dosage of carbohydrate antigen (CA 19-9) serum levels in pancreatic diseases, 38 patients with pancreatic lesions proved at laparotomy were studied. Pancreatic lesions were classified into two groups: a) group I: pancreatic adenocarcinoma (17 cases) b) group II: benign pancreatic diseases (21 cases)
J, Venot +5 more
openaire +1 more source
CA 19–9, GICA (Gastrointestinal Cancer Antigen)
1992Following the detection and clinical exploitation of alphafetoprotein (AFP), calcinoembryonic antigen (CEA), and human chorionic genadotropin (HCG) as first and basic tumor markers, the discovery of blood group-related carbohydrate structures on glycoproteins and glycolipids as indicators of malignancy has opened a wide array of scientific and clinical
openaire +1 more source
European Journal of Surgical Oncology (EJSO), 2007
Although many biochemical markers have been examined in pancreatic cancer none are definitive for pre-operative diagnosis. This systematic review examines studies using biochemical markers for the diagnosis of pancreatic cancer in order to appraise their role in contemporary management algorithms.A search of the MEDLINE database was undertaken using ...
K S, Goonetilleke, A K, Siriwardena
openaire +2 more sources
Although many biochemical markers have been examined in pancreatic cancer none are definitive for pre-operative diagnosis. This systematic review examines studies using biochemical markers for the diagnosis of pancreatic cancer in order to appraise their role in contemporary management algorithms.A search of the MEDLINE database was undertaken using ...
K S, Goonetilleke, A K, Siriwardena
openaire +2 more sources
Clinical value of CA 19-9 (carbohydrate antigen) in gastrointestinal adenocarcinoma.
The Italian journal of surgical sciences, 1985CA 19-9 and CEA serum levels were determined before and 7 days after surgery in 140 patients with gastrointestinal adenocarcinoma, and in 70 patients with gastrointestinal non neoplastic diseases. CA 19-9 test was shown to be positive in 37.9% of colorectal cancer, in 32.6% of gastric cancer and in 77.8% of pancreatic cancer.
MENNINI, Giuseppe +7 more
openaire +2 more sources
Scandinavian Journal of Gastroenterology, 1989
Serum levels of the new tumor-associated marker CA 72-4 were measured in healthy controls (n = 64) and patients with benign (n = 410) or malignant (n = 199) gastrointestinal diseases. A cut-off limit of 4 U/ml was established. Tumor-indicating sensitivity was compared with that of the conventional markers carcinoembryonic antigen (CEA) and CA 19-9.
G, Heptner, S, Domschke, W, Domschke
openaire +2 more sources
Serum levels of the new tumor-associated marker CA 72-4 were measured in healthy controls (n = 64) and patients with benign (n = 410) or malignant (n = 199) gastrointestinal diseases. A cut-off limit of 4 U/ml was established. Tumor-indicating sensitivity was compared with that of the conventional markers carcinoembryonic antigen (CEA) and CA 19-9.
G, Heptner, S, Domschke, W, Domschke
openaire +2 more sources